国内现有的预防用生物制品市场在经历了从计划体制到暴利到目前的微利甚至亏本经营这样一种痛苦的经历后,人们不禁要问:预防用生物制品市场究竟怎么了? 从五十年代开始,为了贯彻党中央的卫生工作应以预防为主的方针,国家陆续在北京、上海等地按当时的大区划分,建立了六大生物制品研究所,即我们俗称的六大所,以生产、研制预防制品和生物制品为主,并在当时的情况下,对这几个生物制品研究所的供应渠道和对象按当时的行政大区划分进行划定。从八十年代末开始,随着改革开放的进一步深入,国家对预防制品采取了两条腿走路的方式:即对于列入国家计划免疫的制品,依然采 After the domestic market for preventive biological products in the country experienced a painful experience from planning system to profiteering to the current low profit or even loss management, one can’t help but ask: What is the market for preventive biological products? From the fifties At the beginning, in order to implement the Party Central Committee’s health work should be based on the principle of prevention, the country has successively established six major biological products research institutes in Beijing, Shanghai and other places according to the division of the then large region, which is commonly known as the six major institutes. The production, development of preventive products and biological products was the mainstay. Under the prevailing circumstances, the supply channels and objects of these Institutes of Biological Products were delineated according to the then administrative divisions. Since the end of the 1980s, with the deepening of reforms and opening up, the state has adopted a two-legged approach to preventing products: that is, for products that are included in the national plan for immunization,